BiotechTube

Minocycline + Placebo

ApprovedCompleted
0 views this week 0 watching⚡ Active
Interest: 43/100
43
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Stress, Psychological

Conditions

Stress, Psychological, Motivation

Trial Timeline

Sep 12, 2022 → Dec 19, 2023

NCT ID
NCT06044090

About Minocycline + Placebo

Minocycline + Placebo is a approved stage product being developed by Johnson & Johnson for Stress, Psychological. The current trial status is completed. This product is registered under clinical trial identifier NCT06044090. Target conditions include Stress, Psychological, Motivation.

What happened to similar drugs?

7 of 20 similar drugs in Stress, Psychological were approved

Approved (7) Terminated (1) Active (13)
✅solifenacinAstellas PharmaApproved
✅duloxetine HClEli LillyApproved
✅Duloxetine hydrochloride + placeboEli LillyApproved
✅Placebo + sertralineJohnson & JohnsonApproved
✅Adjunctive asenapineMerckApproved
✅ZiprasidonePfizerApproved
✅Tramadol + PlaceboBrain BiotechApproved

Hype Score Breakdown

Clinical
20
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT06044090ApprovedCompleted

Competing Products

20 competing products in Stress, Psychological

See all competitors
ProductCompanyStageHype Score
Duloxetine + placeboEli LillyPhase 2
35
agenT-797MiNK TherapeuticsPhase 1
19
Thermal stress and performance without a pre-cooling protocolPetros PharmaceuticalsPre-clinical
16
solifenacinAstellas PharmaApproved
43
SivelestatEli LillyPhase 1/2
32
Duloxetine + PlaceboEli LillyPhase 3
40
DuloxetineEli LillyPhase 3
40
Duloxetine + PlaceboEli LillyPhase 3
40
DuloxetineEli LillyPhase 3
40
Duloxetine hydrochlorideEli LillyPhase 3
36
DuloxetineEli LillyPhase 3
40
duloxetine + PlaceboEli LillyPhase 2
35
Exenatide + InsulinEli LillyPhase 2/3
38
DuloxetineEli LillyPhase 3
40
duloxetine HClEli LillyApproved
43
Orforglipron + PlaceboEli LillyPhase 3
47
Duloxetine hydrochloride + placeboEli LillyApproved
43
Duloxetine + PlaceboEli LillyPhase 3
40
duloxetine + placeboEli LillyPhase 3
40
DuloxetineEli LillyPhase 3
40